Yumanity Therapeutic Headquarters
The links below provide all the necessary information about Yumanity Therapeutic Headquarters. Also there you will find information about the address, phone numbers, emails and much more.
Yumanity Therapeutics Stock Forecast, Price & News (NASDAQ:Y…
- https://www.marketbeat.com/stocks/NASDAQ/YMTX/#:~:text=Yumanity%20Therapeutics%20is%20headquartered%20at%2040%20GUEST%20STREET,at%20%28617%29%20409-5300%20or%20via%20email%20at%20lroth%40burnsmc.com.
- none
Yumanity Therapeutics
- https://www.yumanity.com/
- We would like to show you a description here but the site won’t allow us.
Yumanity Therapeutics Company Profile - Craft
- https://craft.co/yumanity-therapeutics
- Yumanity Therapeutics headquarters is located at 790 Memorial Dr #2c, Cambridge. Where are Yumanity Therapeutics offices? Yumanity Therapeutics has offices in Cambridge and Boston. How many offices does Yumanity Therapeutics have? Yumanity Therapeutics has 2 offices.
Yumanity Therapeutics Corporate Headquarters, Office Locations …
- https://craft.co/yumanity-therapeutics/locations
- Yumanity Therapeutics is headquartered in Cambridge, MA and has 2 office locations across 1 country. View Company Filter locations by country United States Discover additional companies by location with Advanced Search in Craft Learn more All Yumanity Therapeutics Locations Cambridge (HQ), MA United States 790 Memorial Dr #2c Boston, MA
Yumanity Therapeutics - Crunchbase Company Profile
- https://www.crunchbase.com/organization/yumanity-therapeutics
- Headquarters Regions Greater Boston Area, East Coast, New England Founded Date 2014 Founders Susan Lindquist, Tony Coles Operating Status Active Last Funding Type Venture - Series Unknown Legal Name Yumanity Therapeutics Inc. Stock Symbol NASDAQ:YMTX Company Type For Profit Contact Email [email protected] Phone Number (973) 271-6085
Yumanity Therapeutics - Overview, News & Competitors
- https://www.zoominfo.com/c/yumanity-therapeutics-inc/368832865
- Yumanity Therapeutics’s headquarters are in 40 Guest St, Ste 4410, Boston, Massachusetts, 02135, United States What is Yumanity Therapeutics’s phone number? Yumanity Therapeutics’s phone number is (617) 409-5300 What is Yumanity Therapeutics’s official website? Yumanity Therapeutics’s official website is www.yumanity.com
YUMANITY THERAPEUTICS, INC. - MarketScreener.com
- https://www.marketscreener.com/quote/stock/YUMANITY-THERAPEUTICS-IN-117003859/company/
- Yumanity Therapeutics Inc., formerly Proteostasis Therapeutics, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of disease-modifying therapies for neurodegenerative diseases. The Company's technology platform enables the rapid screening for novel disease targets and disease modifying ...
Yumanity Therapeutics Inc - Company Profile and News
- https://www.bloomberg.com/profile/company/PTI:US
- Yumanity Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of novel therapeutics for the treatments for neurodegenerative diseases.
Yumanity Therapeutics Inc - Company Profile and News
- https://www.bloomberg.com/profile/company/8IY:GR
- Company profile page for Yumanity Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information
Investor Overview | Yumanity Therapeutics, Inc.
- https://yumanity.gcs-web.com/
- Yumanity Therapeutics is a clinical-stage biopharmaceutical company that is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. The Company’s most advanced product candidate, YTX-7739, is currently in Phase 1 clinical development for Parkinson ...
Yumanity Therapeutics Reports First Quarter 2022 Financial
- https://www.globenewswire.com/news-release/2022/05/12/2442561/0/en/Yumanity-Therapeutics-Reports-First-Quarter-2022-Financial-Results-and-Recent-Corporate-Developments.html
- 8 hours ago · First Quarter 2022 Financial Highlights. Cash position: As of March 31, 2022, cash, cash equivalents and investments were $17.5 million, compared to $36.5 million as of …
Yumanity Therapeutics (YMTX) Reports Q1 Loss, Misses Revenue …
- https://www.nasdaq.com/articles/yumanity-therapeutics-ymtx-reports-q1-loss-misses-revenue-estimates
- 6 hours ago · Yumanity Therapeutics (YMTX) came out with a quarterly loss of $1.24 per share versus the Zacks Consensus Estimate of a loss of $1.02. This compares to loss of $0.85 per share a year ago. These ...
Yumanity Therapeutics LLC - Company Profiles - BCIQ
- https://www.biocentury.com/companies/yumanity_therapeutics_llc
- For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the …
Did you find out everything you wanted about Yumanity Therapeutic Headquarters?
We are sure that the information collected for you about Yumanity Therapeutic Headquarters turned out to be more than enough.
